Polyphosphate-loaded silk fibroin membrane as hemostatic agent in oral surgery: a pilot study
Popal Z, Nickel K, Wöltje M, Aibibu D, Knipfer C, Smeets R, Renné T
INT J IMPLANT DENT. 2023;9(1):44.

A Flow Cytometry-Based Assay for Procoagulant Platelet Polyphosphate
Labberton L, Long A, Gendler S, Snozek C, Stavrou E, Nickel K, Maas C, Blankenberg S, Hernandez J, Renné T
CYTOM PART B-CLIN CY. 2018;94(2):369-373.

Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases
Nickel K, Long A, Fuchs T, Butler L, Renné T
ARTERIOSCL THROM VAS. 2017;37(1):13-20.

Polyphosphate nanoparticles on the platelet surface trigger contact system activation
Verhoef J, Barendrecht A, Nickel K, Dijkxhoorn K, Kenne E, Labberton L, McCarty O, Schiffelers R, Heijnen H, Hendrickx A, Schellekens H, Fens M, de Maat S, Renné T, Maas C
BLOOD. 2017;129(12):1707-1717.

Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection
Labberton L, Kenne E, Long A, Nickel K, Di Gennaro A, Rigg R, Hernandez J, Butler L, Maas C, Stavrou E, Renné T
NAT COMMUN. 2016;7:12616.

The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies
Nickel K, Labberton L, Long A, Langer F, Fuchs T, Stavrou E, Butler L, Renné T
THROMB RES. 2016;141 Suppl 2:S4-7.

Factor XII: a novel target for safe prevention of thrombosis and inflammation
Kenne E, Nickel K, Long A, Fuchs T, Stavrou E, Stahl F, Renné T
J INTERN MED. 2015;278(6):571-85.

The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis
Nickel K, Ronquist G, Langer F, Labberton L, Fuchs T, Bokemeyer C, Sauter G, Graefen M, Mackman N, Stavrou E, Ronquist G, Renné T
BLOOD. 2015;126(11):1379-89.

Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions
Sala-Cunill A, Björkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, Nickel K, Butler L, Luengo O, Kumar P, Labberton L, Long A, Di Gennaro A, Kenne E, Jämsä A, Krieger T, Schlüter H, Fuchs T, Flohr S, Hassiepen U, Cumin F, McCrae K, Maas C, Stavrou E, Renné T
J ALLERGY CLIN IMMUN. 2015;135(4):1031-1043.e6.

The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities
Worm M, Köhler E, Panda R, Long A, Butler L, Stavrou E, Nickel K, Fuchs T, Renné T
J TRANSL MED. 2015;3(17):247.

In vivo activation and functions of the protease factor XII
Björkqvist J, Nickel K, Stavrou E, Renne T
THROMB HAEMOSTASIS. 2014;112(5):868-875.

A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk
Larsson M, Rayzman V, Nolte M, Nickel K, Björkqvist J, Jämsä A, Hardy M, Fries M, Schmidbauer S, Hedenqvist P, Broomé M, Pragst I, Dickneite G, Wilson M, Nash A, Panousis C, Renné T
SCI TRANSL MED. 2014;6(222):222ra17.

Time-dependent degradation and tissue factor addition mask the ability of platelet polyphosphates in activating factor XII-mediated coagulation
Nickel K, Spronk H, Mutch N, Renné T
BLOOD. 2013;122(23):3847-9.

Letzte Aktualisierung aus dem FIS: 20.04.2024 - 00:48 Uhr